Literature DB >> 15033192

Reduced expression and aberrant localization of p120catenin in human squamous cell carcinoma of the skin.

Yasuko Ishizaki1, Yasufumi Omori, Megumi Momiyama, Yuji Nishikawa, Takuo Tokairin, Motomu Manabe, Katsuhiko Enomoto.   

Abstract

BACKGROUND: p120catenin (p120ctn), a member of the Armadillo protein family, is ubiquitously expressed and binds to classical cadherins together with other catenins to participate in the adherens junction. p120ctn has numerous isoforms generated through extensive splicing and alternative usage of translation initiation codons. Although the involvement of p120ctn in cell growth control has been postulated, little has so far been known about its expression patterns in the skin and epidermal tumors.
OBJECTIVE: To identify the isoforms expressed in benign and malignant keratinocytes and to analyze the expression patterns of p120ctn in epidermal tumor specimens.
METHODS: HaCaT, DJM-1, BSCC-93, HSC-1, HSC-5 and A431 cells along with normal skin tissue were subjected to RT-PCR to identify the expressed isoforms. For immunofluorescence study, surgical specimens including 29 squamous cell carcinomas (SSCs), 4 basal cell carcinomas (BCCs) and 4 seborrheic keratoses as well as 3 normal skin samples were stained with specific antibodies to detect p120ctn and E-cadherin.
RESULTS: RT-PCR revealed that the isoform 3A was predominantly expressed with faint expression of the isoform 4 and that there was no difference in expressed isoforms between the examined cell lines. Immunofluorescent staining indicated that the expression of p120ctn was significantly reduced in all of the examined squamous cell carcinomas and that p120ctn was frequently localized in cytoplasm. In benign tumors and normal samples, p120ctn was properly expressed in cell-cell boundaries. Furthermore, there were several SCCs where E-cadherin continued to be expressed with no expression of p120ctn.
CONCLUSION: Reduced expression and aberrant localization of p120ctn are among the most common events during the development and/or progression of SCCs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033192     DOI: 10.1016/j.jdermsci.2003.12.001

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  12 in total

Review 1.  Phosphorylation and isoform use in p120-catenin during development and tumorigenesis.

Authors:  Ji Yeon Hong; Il-Hoan Oh; Pierre D McCrea
Journal:  Biochim Biophys Acta       Date:  2015-10-23

2.  Divergent roles of p120-catenin isoforms linked to altered cell viability, proliferation, and invasiveness in carcinogen-induced rat skin tumors.

Authors:  Rong Wang; Ying-Shiuan Chen; Wan-Mohaiza Dashwood; Qingjie Li; Christiane V Löhr; Kay Fischer; Emily Ho; David E Williams; Roderick H Dashwood
Journal:  Mol Carcinog       Date:  2017-03-06       Impact factor: 4.784

3.  Altered expression of p120catenin predicts poor outcome in invasive breast cancer.

Authors:  K Talvinen; J Tuikkala; M Nykänen; A Nieminen; J Anttinen; O S Nevalainen; S Hurme; T Kuopio; P Kronqvist
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-12       Impact factor: 4.553

4.  P120ctn overexpression enhances beta-catenin-E-cadherin binding and down regulates expression of survivin and cyclin D1 in BEL-7404 hepatoma cells.

Authors:  Chao-Zan Nong; Li-Li Pan; Wei-Sheng He; Xi-Liang Zha; Hai-Hong Ye; Hua-Yi Huang
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

5.  p120ctn isoform 1 expression significantly correlates with abnormal expression of E-cadherin and poor survival of lung cancer patients.

Authors:  Yuan Miao; Nan Liu; Yong Zhang; Yang Liu; Juan-Han Yu; Shun-Dong Dai; Hong-Tao Xu; En-Hua Wang
Journal:  Med Oncol       Date:  2009-09-11       Impact factor: 3.064

6.  Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters.

Authors:  Bo Zhai; He-Xin Yan; Shu-Qin Liu; Lei Chen; Meng-Chao Wu; Hong-Yang Wang
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

Review 7.  p120catenin alteration in cancer and its role in tumour invasion.

Authors:  Florent Peglion; Sandrine Etienne-Manneville
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-09-23       Impact factor: 6.237

8.  Expression of plakophilins (PKP1, PKP2, and PKP3) in gastric cancers.

Authors:  Guzin G Demirag; Yurdanur Sullu; Dilek Gurgenyatagi; Nilgun O Okumus; Idris Yucel
Journal:  Diagn Pathol       Date:  2011-01-02       Impact factor: 2.644

9.  Altered localization of p120 catenin in the cytoplasm rather than the membrane correlates with poor prognosis in esophageal squamous cell carcinoma.

Authors:  Tian Chen; Chen Wang; Fang Wu; Xuebang Zhang; Han Yang; Xia Deng; Qiancheng He; Wenfeng Li; Gang Li
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

10.  p120-Catenin Is Required for Dietary Calcium Suppression of Oral Carcinogenesis in Mice.

Authors:  Zhongjian Xie; Yuan Yuan; Yi Jiang; Chandrama Shrestha; Ying Chen; Liyan Liao; Shangli Ji; Xiaoge Deng; Eryuan Liao; Daniel D Bikle
Journal:  J Cell Physiol       Date:  2016-11-10       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.